Keyword: Quark Pharmaceuticals

Kiran Mazumdar-Shaw

Biocon, Quark move ahead in India on QPI-1007

Biocon and RNAi firm Quark Pharmaceuticals said the first patient has received a randomized dose in a clinical trial for ocular neuroprotection siRNA (small interfering RNA) candidate QPI-1007.